Skip to Main Content

Author Details

Kimberly Meade-White
National Institutes of Allergy and Infectious Disease, National Institutes of Health
2002
87
33
Nevan J Krogan (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36184852Accelerated DNA vaccine regimen provides protection against Crimean-Congo hemorrhagic fever virus challenge in a macaque model.Mol Ther2023
37866114CD8<sup>+</sup> T-cells target the Crimean-Congo haemorrhagic fever virus Gc protein to control the infection in wild-type mice.EBioMedicine2023
37756057Histopathologic Characterization of Experimental Peracute SARS-CoV-2 Infection in the Syrian Hamster.Vet Sci2023
37611878Favipiravir and Ribavirin protect immunocompetent mice from lethal CCHFV infection.Antiviral Res2023
37731485Immunological correlates of protection afforded by PHV02 live, attenuated recombinant vesicular stomatitis virus vector vaccine against Nipah virus disease.Front Immunol2023
37075079A replicon RNA vaccine can induce durable protective immunity from SARS-CoV-2 in nonhuman primates after neutralizing antibodies have waned.PLoS Pathog2023
37235549Immunocompetent hamsters as a model for orthobunyavirus-induced neuroinvasion and neuropathology.PLoS Negl Trop Dis2023
36508878Distinct VSV-based Nipah virus vaccines expressing either glycoprotein G or fusion protein F provide homologous and heterologous protection in a nonhuman primate model.EBioMedicine2023
35233571Molnupiravir (MK-4482) is efficacious against Omicron and other SARS-CoV-2 variants in the Syrian hamster COVID-19 model.bioRxiv2022
35579953Molnupiravir inhibits SARS-CoV-2 variants including Omicron in the hamster model.JCI Insight2022
35860599Development of a nonhuman primate model for mammalian bornavirus infection.PNAS Nexus2022
36399566SARS-CoV-2 Omicron BA.1 and BA.2 are attenuated in rhesus macaques as compared to Delta.Sci Adv2022
35971544SARS-CoV-2 Omicron BA.1 and BA.2 are attenuated in rhesus macaques as compared to Delta.bioRxiv2022
35907368Replicating RNA vaccination elicits an unexpected immune response that efficiently protects mice against lethal Crimean-Congo hemorrhagic fever virus challenge.EBioMedicine2022
35932641Replicating RNA platform enables rapid response to the SARS-CoV-2 Omicron variant and elicits enhanced protection in naïve hamsters compared to ancestral vaccine.EBioMedicine2022
35982677A replicon RNA vaccine induces durable protective immunity from SARS-CoV-2 in nonhuman primates after neutralizing antibodies have waned.bioRxiv2022
35191378SARS-CoV2 variant-specific replicating RNA vaccines protect from disease following challenge with heterologous variants of concern.Elife2022
35263638SARS-CoV-2 reinfection prevents acute respiratory disease in Syrian hamsters but not replication in the upper respiratory tract.Cell Rep2022
33469217Publisher Correction: ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques.Nature2021
33654106ChAdOx1-vectored Lassa fever vaccine elicits a robust cellular and humoral immune response and protects guinea pigs against lethal Lassa virus challenge.NPJ Vaccines2021
33572859T-Cells and Interferon Gamma Are Necessary for Survival Following Crimean-Congo Hemorrhagic Fever Virus Infection in Mice.Microorganisms2021
33821272Recovery from acute SARS-CoV-2 infection and development of anamnestic immune responses in T cell-depleted rhesus macaques.bioRxiv2021
33922222<i>Mastomys natalensis</i> Has a Cellular Immune Response Profile Distinct from Laboratory Mice.Viruses2021
33754147A single intranasal dose of chimpanzee adenovirus-vectored vaccine protects against SARS-CoV-2 infection in rhesus macaques.Cell Rep Med2021
33532770A single intranasal dose of chimpanzee adenovirus-vectored vaccine protects against SARS-CoV-2 infection in rhesus macaques.bioRxiv2021
33863887Orally delivered MK-4482 inhibits SARS-CoV-2 replication in the Syrian hamster model.Nat Commun2021
33886507Intradermal delivery of a synthetic DNA vaccine protects macaques from Middle East respiratory syndrome coronavirus.JCI Insight2021
33831142Broadly neutralizing monoclonal antibodies protect against multiple tick-borne flaviviruses.J Exp Med2021
34907224A live-attenuated viral vector vaccine protects mice against lethal challenge with Kyasanur Forest disease virus.NPJ Vaccines2021
34931189SARS-CoV2 variant-specific replicating RNA vaccines protect from disease and pathology and reduce viral shedding following challenge with heterologous SARS-CoV2 variants of concern.bioRxiv2021
34724885UK B.1.1.7 (Alpha) variant exhibits increased respiratory replication and shedding in nonhuman primates.Emerg Microbes Infect2021
34159332UK B.1.1.7 variant exhibits increased respiratory replication and shedding in nonhuman primates.bioRxiv2021
34072112Continuing Orthohantavirus Circulation in Deer Mice in Western Montana.Viruses2021
34013879Ebola Virus IgG Seroprevalence in Southern Mali.Emerg Infect Dis2021
34013842Alkhurma haemorrhagic fever virus causes lethal disease in IFNAR<sup>-/-</sup> mice.Emerg Microbes Infect2021
34311582Recovery from Acute SARS-CoV-2 Infection and Development of Anamnestic Immune Responses in T Cell-Depleted Rhesus Macaques.mBio2021
33431511Single-cell RNA sequencing reveals SARS-CoV-2 infection dynamics in lungs of African green monkeys.Sci Transl Med2021
33416494Immunocompetent mouse model for Crimean-Congo hemorrhagic fever virus.Elife2021
32511299Respiratory disease and virus shedding in rhesus macaques inoculated with SARS-CoV-2.bioRxiv2020
31934358A single dose of a vesicular stomatitis virus-based influenza vaccine confers rapid protection against H5 viruses from different clades.NPJ Vaccines2020
31682727Rousettus aegyptiacus Bats Do Not Support Productive Nipah Virus Replication.J Infect Dis2020
33251966Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infection.Emerg Microbes Infect2020
33052329Orally delivered MK-4482 inhibits SARS-CoV-2 replication in the Syrian hamster model.Res Sq2020
33090972Hydroxychloroquine prophylaxis and treatment is ineffective in macaque and hamster SARS-CoV-2 disease models.JCI Insight2020
32577633Hydroxychloroquine Proves Ineffective in Hamsters and Macaques Infected with SARS-CoV-2.bioRxiv2020
32577525A single dose of ChAdOx1 MERS provides protective immunity in rhesus macaques.Sci Adv2020
32995767Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infection.bioRxiv2020
32731258ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques.Nature2020
32645335Efficacy of favipiravir (T-705) against Crimean-Congo hemorrhagic fever virus infection in cynomolgus macaques.Antiviral Res2020
32641828Envelope protein ubiquitination drives entry and pathogenesis of Zika virus.Nature2020
  • 1 - 50 of 87

Recommended Authors

Center for Pathogen Research, University of Maryland School of Medicine
Career Start Year 2017
Number of shared co-authors 4
Center for Innate Immunity and Immune Disease, University of Washington
Career Start Year 2016
Number of shared co-authors 1
University of North Carolina at Chapel Hill
Career Start Year 2014
Number of shared co-authors 3
Center for Global Infectious Disease Research, Seattle Children's Research Institute
Career Start Year 2013
Number of shared co-authors 0
University of Texas Medical Branch, USA Galveston National Laboratory
Career Start Year 2012
Number of shared co-authors 1
University of Texas Medical Branch
Career Start Year 2009
Number of shared co-authors 8
University of Texas Medical Branch
Career Start Year 2008
Number of shared co-authors 10
University of Texas Medical Branch
Career Start Year 2008
Number of shared co-authors 15
and Lineberger Comprehensive Cancer Center, University of North Carolina System
Career Start Year 2006
Number of shared co-authors 2
National Center for Toxicological Research
Career Start Year 2005
Number of shared co-authors 3
The Scripps Research Institute
Career Start Year 2004
Number of shared co-authors 1
Lankenau Institute for Medical Research
Career Start Year 2004
Number of shared co-authors 2
University of North Carolina at Chapel Hill
Career Start Year 2003
Number of shared co-authors 5
Center for Infectious Diseases Research, Walter Reed Army Institute of Research
Career Start Year 2002
Number of shared co-authors 4
University of North Carolina at Chapel Hill
Career Start Year 2002
Number of shared co-authors 4
University of Colorado Anschutz Medical Campus
Career Start Year 2001
Number of shared co-authors 1
Texas Biomedical Research Institute
Career Start Year 2001
Number of shared co-authors 6
Washington University School of Medicine
Career Start Year 1996
Number of shared co-authors 4
The Rockefeller University
Career Start Year 1995
Number of shared co-authors 0
Center for Pathogen Research, University of Maryland School of Medicine
Career Start Year 1993
Number of shared co-authors 5
University of North Carolina at Chapel Hill
Career Start Year 1993
Number of shared co-authors 4
University of North Carolina at Chapel Hill
Career Start Year 1993
Number of shared co-authors 0
University of Manitoba
Career Start Year 1991
Number of shared co-authors 6
The University of Texas Medical Branch
Career Start Year 1991
Number of shared co-authors 2
University of North Carolina at Chapel Hill.
Career Start Year 1990
Number of shared co-authors 5
College of Veterinary Medicine, Kansas State University
Career Start Year 1988
Number of shared co-authors 4
Erasmus Medical Center
Career Start Year 1986
Number of shared co-authors 3
University of North Carolina
Career Start Year 1981
Number of shared co-authors 8
Tulane University School of Medicine
Career Start Year 1974
Number of shared co-authors 3
University of Texas Medical Branch at Galveston
Career Start Year 1970
Number of shared co-authors 1

Collaborators

National Institute of Allergy and Infectious Diseases, National Institutes of Health
Co-authored papers 14
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Co-authored papers 6
Washington University School of Medicine
Co-authored papers 3
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Co-authored papers 3
National Institute of Allergy and Infectious Diseases
Co-authored papers 3
Center for Innate Immunity and Immune Disease, University of Washington
Co-authored papers 3
Co-authored papers 2
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Co-authored papers 2
National Institute of Allergy and Infectious Diseases
Co-authored papers 2
Wistar Institute
Co-authored papers 2
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Co-authored papers 2
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Co-authored papers 2
National Institute On Aging
Co-authored papers 2
National Institute of Allergy and Infectious Diseases
Co-authored papers 1
University of California San Francisco
Co-authored papers 1
Co-authored papers 1
University of Texas Medical Branch, 301 University Boulevard
Co-authored papers 1
University of Texas Medical Branch
Co-authored papers 1
University of Texas Medical Branch
Co-authored papers 1
Gladstone Institutes
Co-authored papers 1
University of Texas Medical Branch
Co-authored papers 1
National Institute of Allergy and Infectious Diseases
Co-authored papers 1
Sidney Kimmel Medical College, Thomas Jefferson University
Co-authored papers 1
University of Texas Medical Branch
Co-authored papers 1
Carver College of Medicine, University of Iowa
Co-authored papers 1
Washington University School of Medicine
Co-authored papers 1
University of Texas Medical Branch
Co-authored papers 1
University of Texas Medical Branch
Co-authored papers 1
Wuhan Institute of Virology, Chinese Academy of Sciences
Co-authored papers 1
Washington University in St. Louis
Co-authored papers 1